>>> US After Hours Summary: LLNW +12%, ADBE +9%, URI / KMI +2% higher


After Hours Summary: LLNW +12%, ADBE +9%, URI / KMI +2% higher and EBAY -6%, AA / HCA -1% lower following earnings/guidance

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: LLNW +11.6%, ADBE +8.8%, URI +1.9%, (also will resume its pre-existing $1 billion program to repurchase shares of its common stock), KMI +1.8%

Companies trading higher in after hours in reaction to news: CEI +26.9% (low cap / thinly traded name higher after company discloses Interim CEO, Richard Azar, has released a letter to shareholders), CNAT +6.8% (EMA granted orphan designation to Conatus' drug candidate IDN-7314 for the treatment of primary sclerosing cholangitis which can lead to cirrhosis and liver failure), JUNO +3.9% (higher following Kite CAR T news), GILD +3.2% (Gilead Sciences' Kite confirms Yescarta FDA approval as first CAR T therapy for the treatment of adult patients with relapsed or refractory large B-Cell lymphoma after two or more lines of systemic therapy), WGO +1.8% (ahead of earnings), BMRN +1.6% (rebounding from today's weakness on development portfolio update/reaffirmed guidance), W +0.9% (initiated with Buy and $85 tgt at MKM Partners)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: EBAY -6.1%, STLD -2.9% (ticking lower), HXL -1.6% (light volume), OIS -1.3% (revises guidance due to the impacts of Hurricane Harvey), AA -1.2%, HCA -1.2%, YRCW -1%, AXP -0.5% (also appointed Stephen J. Squeri CEO and elected him Chairman of the Board, each effective February 1, 2018)

Companies trading lower in after hours in reaction to news: OPTT -25% (to offer shares of common stock), ESTE -6.5% (provided Q3 update and revised 2017 capital expenditures downward; commences underwritten public offering of 4.5 mln shares of Class A common stock), PEGI -3.6% (ommences 8 mln common stock offering), RXDX -3.4% (files mixed securities shelf offering; commences $125 mln common stock offering), THC -2.1%  and CYH -1.3% (on HCA guidance), APRN -0.6% (implements company-wide realignment, reducung headcount by ~6%)